Credit Suisse’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38,602
| Closed | -$103K | – | 3267 |
|
|
2023
Q1 | $103K | Buy |
38,602
+4,013
| +12% | +$10.8K | ﹤0.01% | 3188 |
|
|
2022
Q4 | $188K | Buy |
+34,589
| New | +$188K | ﹤0.01% | 3186 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4358 |
|
|
2022
Q2 | $0 | Sell |
1
-22,128
| -100% | – | ﹤0.01% | 4399 |
|
|
2022
Q1 | $168K | Buy |
22,129
+744
| +3% | +$5.65K | ﹤0.01% | 3396 |
|
|
2021
Q4 | $218K | Sell |
21,385
-6,027
| -22% | -$61.4K | ﹤0.01% | 3414 |
|
|
2021
Q3 | $367K | Buy |
27,412
+7,034
| +35% | +$94.2K | ﹤0.01% | 3174 |
|
|
2021
Q2 | $448K | Sell |
20,378
-2,644
| -11% | -$58.1K | ﹤0.01% | 3084 |
|
|
2021
Q1 | $554K | Sell |
23,022
-48,818
| -68% | -$1.17M | ﹤0.01% | 2894 |
|
|
2020
Q4 | $1.29M | Sell |
71,840
-15,820
| -18% | -$284K | ﹤0.01% | 2401 |
|
|
2020
Q3 | $1.01M | Buy |
87,660
+42,057
| +92% | +$486K | ﹤0.01% | 2260 |
|
|
2020
Q2 | $1.11M | Buy |
45,603
+23,159
| +103% | +$562K | ﹤0.01% | 2247 |
|
|
2020
Q1 | $248K | Sell |
22,444
-5,613
| -20% | -$62K | ﹤0.01% | 2934 |
|
|
2019
Q4 | $742K | Buy |
28,057
+3,108
| +12% | +$82.2K | ﹤0.01% | 2697 |
|
|
2019
Q3 | $568K | Buy |
24,949
+7,584
| +44% | +$173K | ﹤0.01% | 2730 |
|
|
2019
Q2 | $532K | Buy |
17,365
+2,290
| +15% | +$70.2K | ﹤0.01% | 2746 |
|
|
2019
Q1 | $250K | Buy |
15,075
+3,594
| +31% | +$59.6K | ﹤0.01% | 3102 |
|
|
2018
Q4 | $219K | Sell |
11,481
-7,708
| -40% | -$147K | ﹤0.01% | 3113 |
|
|
2018
Q3 | $1M | Buy |
19,189
+2,071
| +12% | +$108K | ﹤0.01% | 2423 |
|
|
2018
Q2 | $744K | Buy |
17,118
+9,244
| +117% | +$402K | ﹤0.01% | 2771 |
|
|
2018
Q1 | $292K | Buy |
+7,874
| New | +$292K | ﹤0.01% | 3162 |
|